top of page
Get in touch
Menu
Close
About us
The science
The team
The opportunity
The news
Let's transform lives together
First name
*
Last name
*
Your Email
*
Write your short message here
Yes, please add me to your contacts
*
Submit
Our latest news
Dan Williams discusses gene silencing in this important piece for Drug Target Review
Apr 16
SynaptixBio’s fourth anniversary celebrated in The Lifesciences Magazine
Apr 16
In a major article for Drug Discovery World, Dan Williams discussed the opportunities for ASO-based therapies
Apr 16
In a major article for Pharmaceutical Market Europe, SynaptixBio explains the science behind gene silencing technology
Jan 30
Dan Williams discusses SynaptixBio’s history, status, and aspirations in a major interview for leading US biotech podcast RAREcast
Jan 9
The market for ‘gene silencing’ therapies is set to explode
Dec 16, 2024
Amy Sheridan-Hill, co-founder of the H-ABC Foundation, and Dan Williams in major Mirror story about hopes for new drug
Oct 31, 2024
SynaptixBio’s collaboration with leading global drug researcher Evotec featured in European Biotechnology Magazine
Aug 23, 2024
Dan Williams and Amy Sheridan-Hill, whose son Frankie suffers from H-ABC, interviewed for the Evening Standard.
Jul 12, 2024
Dan Williams interviewed for leading podcast, Beyond Biotech
Jul 12, 2024
Leading biotech appoints senior industry figure as Chief Medical Officer to define clinical strategy and oversee trials
Jun 11, 2024
In a major article, Dan Williams considers how to overcome obstacles in rare disease treatment
Jun 11, 2024
SynaptixBio awarded second FDA Orphan Drug Designation to boost search for rare disease therapies
Apr 30, 2024
Bioscience Today features major Dan Williams article about collaboration driving rare disease drug development
Apr 30, 2024
Dan Williams says Big Pharma could help accelerate market introduction for rare disease drugs
Apr 29, 2024
Dan Williams interviewed for prestigious journal - Major International Clinical Trials feature showcases SynaptixBio story
Dec 23, 2023
SynaptixBio awarded prestigious Innovate UK grant to expand search for rare disease therapies
Dec 23, 2023
Leading biotech firm welcomes new NHS rapid diagnostic service for rare diseases, but says wider newborn screening is key
Dec 23, 2023
BBC features TUBB4A leukodystrophy case study – Dan Williams contribution highlights lack of widespread awareness of rare diseases
Dec 23, 2023
Oxford biotech firm secures £13.2m to develop first treatment for rare, incurable, deadly disease.
Apr 28, 2023
About us
The science
The team
The opportunity
The news
bottom of page